News
A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
Several women who have reported improvements in symptoms of polycystic ovary syndrome, a common hormonal disorder, after ...
14h
DPA International on MSNResearch shows many people who stop weight loss drugs regain weightPatients prescribed drugs to help them lose weight may experience a rebound in weight gain after stopping their prescription, ...
Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...
Zepbound led to an average weight loss of 20.2 percent compared to Wegovy's 13.7 percent. We talked with healthcare experts to understand the study’s findings, ...
Zepbound, a weight loss drug by Eli Lily, received FDA approval. How the tirzepatide-containing drug works, potential side effects, and insurance coverage.
People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in the first head-to-head study of the blockbuster medications.
Novo Nordisk's weight-loss medication, Wegovy, uses semaglutide, which only focuses on GLP-1. That difference translated to greater weight loss with Zepbound than Wegovy, a recent study found.
A cutting-edge mouse study reveals that tirzepatide, the dual GLP-1/GIP drug already hailed for impressive weight loss, does more than trim fat: it slashes the growth of obesity-linked breast tumors.
UnitedHealth Group's pharmacy benefits manager, OptumRx Inc., was hit with an Employee Retirement Income Security Act of 1974 ...
The newest weight loss drug on the market is facing a shortage of supply, according to the U.S. Food and Drug Administration.. Some dosages of Zepbound are in limited supply through the end of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results